Skip to main content
Log in
Sciensano
Support
Belgian Genetic Tests database
Toggle navigation
Main navigation
Home
Genetic tests
Analytes
Diseases
Labs
Guide
Contact
Genetic tests
20
50
100
Search
Full name
Analytes
Gene panels
Disease
Laboratory
Colon carcinoma (hereditary/familial) (gene panel)
Colon carcinoma (hereditary/familial) (gene panel) (12 genes) - VUB
APC-related attenuated familial adenomatous polyposis
,
Familial adenomatous polyposis
,
Familial colorectal cancer Type X
,
Generalized juvenile polyposis/juvenile polyposis coli
,
Hereditary mixed polyposis syndrome
,
Hereditary nonpolyposis colorectal cancer
,
Lynch syndrome
,
MUTYH-related attenuated familial adenomatous polyposis
Centrum Medische Genetica - UZ Brussel VUB
Metastatic Breast or Pancreatic or Prostate Cancer
BRCA1
,
BRCA2
Centrum Menselijke Erfelijkheid - KUL
Myeloid/lymphoid neoplasms with germline predisposition
Centre de Génétique Humaine - CHU Sart-Tilman
Erythrocytoses, polycythémies, thrombocytoses et neutropénies congénitales (gene panel)
Erythocyoses, polycythémies, thrombocytoses congénitales (gene panel) - ULG
Centre de Génétique Humaine - CHU Sart-Tilman
Breast Cancer Trial
BRCA1
,
BRCA2
Centrum Menselijke Erfelijkheid - KUL
41 pharmacogenes analysis
pharmacogenes analysis
Centre de Génétique Médicale UCL
Somatic analysis of the BRCA genes (2 genes)
BRCA1
,
BRCA2
Centrum Menselijke Erfelijkheid - KUL
Breast and Ovarian Cancer, HBOC, Familial (17 genes)
BRCA1
,
BRCA2
,
TP53
,
PALB2
,
CHEK2
,
ATM
,
BRIP1
,
RAD51C
,
RAD51D
,
MLH1
,
MSH2
,
MSH6
,
BARD1
,
CDH1
,
EPCAM
,
PMS2
,
PTEN
Hereditary breast and/or ovarian cancer syndrome
Centre de Génétique Médicale UCL
Resistance to vitamin K antagonists - VKORC1 sequencing (all exons ) - Pharmacogenetics
VKORC1
Resistance to vitamin K antagonists
,
Prediction of resistance to vitamin K antagonists
Centre de Génétique Médicale UCL
5-fluorouracil (5-FU) toxicity - DPYD sequencing (all exons) - Pharmacogenetics
DPYD
5-fluorouracil toxicity
Centre de Génétique Médicale UCL
CYP2D6 genotyping (full gene sequencing + pseudogene and CNV analysis)- drug metabolism - Pharmacogenetics
CYP2D6
Codeine toxicity
,
Resistance to tamoxifene
,
Antidepressant or antipsychotic toxicity or dose selection
Centre de Génétique Médicale UCL
TPMT and NUDT15 sequencing - Pharmacogenetics
TPMT
,
NUDT15
Cisplatin toxicity
,
Azathioprine or 6-mercatopurine toxicity or dose selection
Centre de Génétique Médicale UCL
Breast and Ovarian Cancer, HBOC, Hereditary
Breast and ovarian cancer - UGent
Hereditary breast cancer
,
Hereditary breast and/or ovarian cancer syndrome
Centrum Medische Genetica - UZ Gent
Somatic analysis of the BRCA genes in the context of ovarian cancer treatment (2 genes)
BRCA1
,
BRCA2
Centrum Medische Genetica - UZ Gent
Abacavir toxicity (HLA-B*57:01 genotyping) - Pharmacogenetics
HLA-B
Abacavir toxicity
Centrum Medische Genetica - UZ Gent
Somatic analysis of the BRCA genes in the context of ovarian cancer treatment (2 genes)
BRCA1
,
BRCA2
Centre de Génétique-Institut de Pathologie et de Génétique (IPG)
Thiopurine S-Methyltransferase deficiency - TPMT genotyping c.238G>C (rs1800462); c.460G>A (rs1800460); c.719A>G (rs1142345)) - Pharmacogenetics
TPMT
Azathioprine or 6-mercatopurine toxicity or dose selection
Centre de Génétique-Institut de Pathologie et de Génétique (IPG)
Breast cancer, hereditary (gene panel)
Extended Breast Cancer Panel (26 gene) - VUB
Centrum Medische Genetica - UZ Brussel VUB
Abacavir toxicity (HLA-B*57:01 genotyping) - Pharmacogenetics
HLA-B
Abacavir toxicity
Centrum Medische Genetica - UZ Brussel VUB
Pagination
Current page
1
Page
2
Next page
Next ›
Last page
Last »
Download XLSX
Download PDF
Did not find what you were looking for? Contact us through the support center.
Read more